Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12851-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12851-1-AP, RRID:AB_2081366
- Product name
- CMIP antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CMIP antibody (Cat. #12851-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells.
Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
CMIP Promotes Proliferation and Metastasis in Human Glioma.
c‑Maf inducing protein inhibits cofilin‑1 activity and alters podocyte cytoskeleton organization.
CMIP is oncogenic in human gastric cancer cells.
Induction of C-Mip by IL-17 Plays an Important Role in Adriamycin-Induced Podocyte Damage.
Inhibition of nephrin activation by c-mip through Csk-Cbp-Fyn axis plays a critical role in Angiotensin II-induced podocyte damage.
Xiang R, Han X, Ding K, Wu Z
Pathology, research and practice 2020 Feb;216(2):152776
Pathology, research and practice 2020 Feb;216(2):152776
Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
Li TS, Chen L, Wang SC, Yang YZ, Xu HJ, Gu HM, Zhao XJ, Dong P, Pan Y, Shang ZQ, Zhang XQ, Kong LD
Biochemical pharmacology 2019 Aug;166:139-152
Biochemical pharmacology 2019 Aug;166:139-152
CMIP Promotes Proliferation and Metastasis in Human Glioma.
Wang B, Wu ZS, Wu Q
BioMed research international 2017;2017:5340160
BioMed research international 2017;2017:5340160
c‑Maf inducing protein inhibits cofilin‑1 activity and alters podocyte cytoskeleton organization.
Yu L, Ye J, Liu Q, Feng J, Gu X, Sun Q, Lu G
Molecular medicine reports 2017 Oct;16(4):4955-4963
Molecular medicine reports 2017 Oct;16(4):4955-4963
CMIP is oncogenic in human gastric cancer cells.
Zhang J, Huang J, Wang X, Chen W, Tang Q, Fang M, Qian Y
Molecular medicine reports 2017 Nov;16(5):7277-7286
Molecular medicine reports 2017 Nov;16(5):7277-7286
Induction of C-Mip by IL-17 Plays an Important Role in Adriamycin-Induced Podocyte Damage.
Liu Y, Su L, Lin Q, Han Y, You P, Fan Q
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2015;36(4):1274-90
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2015;36(4):1274-90
Inhibition of nephrin activation by c-mip through Csk-Cbp-Fyn axis plays a critical role in Angiotensin II-induced podocyte damage.
Yu L, Lin Q, Feng J, Dong X, Chen W, Liu Q, Ye J
Cellular signalling 2013 Mar;25(3):581-8
Cellular signalling 2013 Mar;25(3):581-8
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Raji cells were subjected to SDS PAGE followed by western blot with 12851-1-AP(CMIP antibody) at dilution of 1:400
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human testis using 12851-1-AP(CMIP antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CMIP antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CMIP. This antibody recognizes human, mouse, rat antigen. The CMIP antibody has been validated for the following applications: ELISA, WB, IHC analysis.